TRANCE/RANKL plasma levels have also been reported lower in patients with nonalcoholic fatty liver disease (Nikseresht et al., 2020), a condition related to insulin resistance and obesity. The gene discussed is TNFSF11; the disease is metabolic dysfunction-associated steatotic liver disease.